Active Filter(s):
Details:
ERYTECH Announces a Poster Presentation for TRYbeCA1 at the ASCO 2020 Nasdaq:ERYP.
Lead Product(s): Asparagine, L-,Paclitaxel,Gemcitabine
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Phase III Product Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 24, 2020